StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc. (TMO) operating KPIs

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$697.00−12.18 (-1.72%)

Close on Oct 30, 2026Market cap $257.71BP/E 36.8Yield 0.25%

Thermo Fisher Scientific lợi nhuận hoạt động phân khúc (Segment Income) — Specialty Diagnostics ($M)

Bóc tách đầy đủ doanh thu ngoại vi/nội bộ, Giá vốn, SG&A, R&D, Tài sản vận hành (AR + Inventory), CapEx và Khấu hao theo chuẩn kế toán mới ASU 2023-07.

QuarterlyAnnual
Latest, Q3 2026
341
Period ended Sep 30, 2026
Change on a year earlier
+6.2%
321 in Q3 2025
History
19 quarters
Since Q1 2022
Sources
7
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedLợi nhuận hoạt động phân khúc (Segment Income) — Specialty Diagnostics ($M)Year on yearSource
Q3 2026Sep 30, 2026341+6.2%Q3 2026 Reconciliation of Financial Information ↗
Q2 2026Jun 30, 2026334+9.2%Q3 2026 Reconciliation of Financial Information ↗
Q1 2026Mar 31, 2026313+3.0%Q3 2026 Reconciliation of Financial Information ↗
Q4 2025Dec 31, 2025324+18.7%Q3 2026 Reconciliation of Financial Information ↗
Q3 2025Sep 30, 2025321+9.6%Q3 2026 Reconciliation of Financial Information ↗
Q2 2025Jun 30, 2025306+2.3%Q3 2026 Reconciliation of Financial Information ↗
Q1 2025Mar 31, 2025304+3.4%Q3 2026 Reconciliation of Financial Information ↗
Q4 2024Dec 31, 2024273+3.4%Q4 & FY2025 Reconciliation of Financial Information ↗
Q3 2024Sep 30, 2024293+3.5%Q4 & FY2025 Reconciliation of Financial Information ↗
Q2 2024Jun 30, 2024299+0.7%Q4 & FY2025 Reconciliation of Financial Information ↗
Q1 2024Mar 31, 2024294+5.0%Q4 & FY2025 Reconciliation of Financial Information ↗
Q4 2023Dec 31, 2023264+26.9%Q4 & FY2024 Reconciliation of Financial Information ↗
Q3 2023Sep 30, 2023283+28.6%Q4 & FY2024 Reconciliation of Financial Information ↗
Q2 2023Jun 30, 2023297+22.2%Q4 & FY2024 Reconciliation of Financial Information ↗
Q1 2023Mar 31, 2023280-20.7%Q4 & FY2024 Reconciliation of Financial Information ↗
Q4 2022Dec 31, 2022208–SEC Form 8-K (8k_2023Q4, filed 2024-01-31) ↗

Breakdown

What makes up lợi nhuận hoạt động phân khúc (segment income) — specialty diagnostics

Cite this data

StockData. (2026). Thermo Fisher Scientific Lợi nhuận hoạt động phân khúc (Segment Income) — Specialty Diagnostics ($M), quarterly Q1 2022–Q3 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/seg_income_sd

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.